Literature DB >> 11676832

Induction of apoptosis in melanoma cell lines by p53 and its related proteins.

T Yamashita1, T Tokino, H Tonoki, T Moriuchi, H Y Jin, F Omori, K Jimbow.   

Abstract

Melanoma cells rarely contain mutant p53 and hardly undergo apoptosis by wild-type p53. By using recombinant adenoviruses that express p53 or p53-related p51A or p73beta, we tested their apoptotic activities in melanoma cells. Yeast functional assay revealed a mutation of p53 at the 258th codon (AAA [K] instead of GAA [E]) in one cell line, 70W, out of six human melanoma cell lines analyzed (SK-mel-23, SK-mel-24, SK-mel-118, TXM18, 70W, and G361). Adenovirus-mediated transfer of p53, p51A, and/or p73beta suppressed growth and induced apoptotic DNA fragmentation of SK-mel-23, SK-mel-118, and 70W cells. Interestingly, p51A induced DNA fragmentation in them more significantly than p53 and p73beta. By Western blotting we analyzed levels of apoptosis-related proteins in cells expressing p53 family members. Apoptotic Bax and antiapoptotic Bcl-2 were not significantly upregulated or downregulated by expression of p53, p51A, or p73beta, except for p53-expressing 70W cells, which contained a larger amount of Bax protein than LacZ-expressing cells. Activation of caspase-3 was demonstrated only in p51A-expressing SK-mel-118 cells. We show here that p51A can mediate apoptosis in both wild-type and mutant p53-expressing melanoma cells more significantly than p53 and p73beta. It is also suggested that in melanoma cells (i) cellular target protein(s) other than Bcl-2 and Bax might be responsible for induction of p51A-mediated apoptosis and (ii) caspase-3 is not always involved in the apoptosis by p53 family members.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11676832     DOI: 10.1046/j.0022-202x.2001.01464.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  1 in total

1.  Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene.

Authors:  Hitoshi Yamazaki; Tsuyoshi Chijiwa; Yoshimasa Inoue; Yoshiyuki Abe; Hiroshi Suemizu; Kenji Kawai; Masatoshi Wakui; Daisuke Furukawa; Masaya Mukai; Sadahito Kuwao; Makoto Saegusa; Masato Nakamura
Journal:  Exp Ther Med       Date:  2012-02-28       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.